We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Centogene AG and Evotec have entered into a global strategic collaboration agreement for joint drug discovery projects focused on developing compounds to treat rare genetic diseases.